Next-generation sequencing (NGS) has enabled us to extract genetic information from samples faster, more reliably, and at lower cost than ever before. Getting your DNA ready for sequencing requires the preparation of a sequencing library as well as a few other steps that depend on the type of sample and the NGS platform.These steps include DNA extraction, amplification, library preparation, selection or purification, and quality control.
The global Next Generation Sequencing Sample Preparation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Next Generation Sequencing Sample Preparation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation Sequencing Sample Preparation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next Generation Sequencing Sample Preparation in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next Generation Sequencing Sample Preparation include Agilent Technologies, Myriad Genetics, Oxford Nanopore Technologies, Foundation Medicine, Genomatix GmbH, Illumina, Pacific Biosciences of California, Partek Incorporated and Perkin Elmer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing Sample Preparation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing Sample Preparation.
Report Scope
The Next Generation Sequencing Sample Preparation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencing Sample Preparation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Sequencing Sample Preparation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Myriad Genetics
Oxford Nanopore Technologies
Foundation Medicine
Genomatix GmbH
Illumina
Pacific Biosciences of California
Partek Incorporated
Perkin Elmer
PierianDx
QIAGEN
Quest Diagnostics Incorporated
Thermo Fisher Scientific
Congenica
DNASTAR
Eurofins Scientific
Roche
BGI
Bio-Rad Laboratories
Macrogen
Segment by Type
NGS Library Preparation Kits
Semi-Automated Library Preparation
Automated Library Preparation
Clonal Amplification
Segment by Application
Oncology
Clinical Investigation
Reproductive Health
HLA Typing/Immune System Monitoring
Metagenomics
Agrigenomics & Forensics
Consumer Genomics
Epidemiology & Drug Development
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencing Sample Preparation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing Sample Preparation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 NGS Library Preparation Kits
1.2.3 Semi-Automated Library Preparation
1.2.4 Automated Library Preparation
1.2.5 Clonal Amplification
1.3 Market by Application
1.3.1 Global Next Generation Sequencing Sample Preparation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Clinical Investigation
1.3.4 Reproductive Health
1.3.5 HLA Typing/Immune System Monitoring
1.3.6 Metagenomics
1.3.7 Agrigenomics & Forensics
1.3.8 Consumer Genomics
1.3.9 Epidemiology & Drug Development
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing Sample Preparation Market Perspective (2019-2030)
2.2 Next Generation Sequencing Sample Preparation Growth Trends by Region
2.2.1 Global Next Generation Sequencing Sample Preparation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Sequencing Sample Preparation Historic Market Size by Region (2019-2024)
2.2.3 Next Generation Sequencing Sample Preparation Forecasted Market Size by Region (2025-2030)
2.3 Next Generation Sequencing Sample Preparation Market Dynamics
2.3.1 Next Generation Sequencing Sample Preparation Industry Trends
2.3.2 Next Generation Sequencing Sample Preparation Market Drivers
2.3.3 Next Generation Sequencing Sample Preparation Market Challenges
2.3.4 Next Generation Sequencing Sample Preparation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing Sample Preparation Players by Revenue
3.1.1 Global Top Next Generation Sequencing Sample Preparation Players by Revenue (2019-2024)
3.1.2 Global Next Generation Sequencing Sample Preparation Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Sequencing Sample Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing Sample Preparation Revenue
3.4 Global Next Generation Sequencing Sample Preparation Market Concentration Ratio
3.4.1 Global Next Generation Sequencing Sample Preparation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing Sample Preparation Revenue in 2023
3.5 Next Generation Sequencing Sample Preparation Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing Sample Preparation Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing Sample Preparation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing Sample Preparation Breakdown Data by Type
4.1 Global Next Generation Sequencing Sample Preparation Historic Market Size by Type (2019-2024)
4.2 Global Next Generation Sequencing Sample Preparation Forecasted Market Size by Type (2025-2030)
5 Next Generation Sequencing Sample Preparation Breakdown Data by Application
5.1 Global Next Generation Sequencing Sample Preparation Historic Market Size by Application (2019-2024)
5.2 Global Next Generation Sequencing Sample Preparation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Sequencing Sample Preparation Market Size (2019-2030)
6.2 North America Next Generation Sequencing Sample Preparation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Sequencing Sample Preparation Market Size by Country (2019-2024)
6.4 North America Next Generation Sequencing Sample Preparation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing Sample Preparation Market Size (2019-2030)
7.2 Europe Next Generation Sequencing Sample Preparation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Sequencing Sample Preparation Market Size by Country (2019-2024)
7.4 Europe Next Generation Sequencing Sample Preparation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing Sample Preparation Market Size (2019-2030)
8.2 Asia-Pacific Next Generation Sequencing Sample Preparation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Sequencing Sample Preparation Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Sequencing Sample Preparation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing Sample Preparation Market Size (2019-2030)
9.2 Latin America Next Generation Sequencing Sample Preparation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Sequencing Sample Preparation Market Size by Country (2019-2024)
9.4 Latin America Next Generation Sequencing Sample Preparation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing Sample Preparation Market Size (2019-2030)
10.2 Middle East & Africa Next Generation Sequencing Sample Preparation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Sequencing Sample Preparation Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Sequencing Sample Preparation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Next Generation Sequencing Sample Preparation Introduction
11.1.4 Agilent Technologies Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Myriad Genetics
11.2.1 Myriad Genetics Company Detail
11.2.2 Myriad Genetics Business Overview
11.2.3 Myriad Genetics Next Generation Sequencing Sample Preparation Introduction
11.2.4 Myriad Genetics Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.2.5 Myriad Genetics Recent Development
11.3 Oxford Nanopore Technologies
11.3.1 Oxford Nanopore Technologies Company Detail
11.3.2 Oxford Nanopore Technologies Business Overview
11.3.3 Oxford Nanopore Technologies Next Generation Sequencing Sample Preparation Introduction
11.3.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.3.5 Oxford Nanopore Technologies Recent Development
11.4 Foundation Medicine
11.4.1 Foundation Medicine Company Detail
11.4.2 Foundation Medicine Business Overview
11.4.3 Foundation Medicine Next Generation Sequencing Sample Preparation Introduction
11.4.4 Foundation Medicine Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.4.5 Foundation Medicine Recent Development
11.5 Genomatix GmbH
11.5.1 Genomatix GmbH Company Detail
11.5.2 Genomatix GmbH Business Overview
11.5.3 Genomatix GmbH Next Generation Sequencing Sample Preparation Introduction
11.5.4 Genomatix GmbH Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.5.5 Genomatix GmbH Recent Development
11.6 Illumina
11.6.1 Illumina Company Detail
11.6.2 Illumina Business Overview
11.6.3 Illumina Next Generation Sequencing Sample Preparation Introduction
11.6.4 Illumina Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.6.5 Illumina Recent Development
11.7 Pacific Biosciences of California
11.7.1 Pacific Biosciences of California Company Detail
11.7.2 Pacific Biosciences of California Business Overview
11.7.3 Pacific Biosciences of California Next Generation Sequencing Sample Preparation Introduction
11.7.4 Pacific Biosciences of California Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.7.5 Pacific Biosciences of California Recent Development
11.8 Partek Incorporated
11.8.1 Partek Incorporated Company Detail
11.8.2 Partek Incorporated Business Overview
11.8.3 Partek Incorporated Next Generation Sequencing Sample Preparation Introduction
11.8.4 Partek Incorporated Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.8.5 Partek Incorporated Recent Development
11.9 Perkin Elmer
11.9.1 Perkin Elmer Company Detail
11.9.2 Perkin Elmer Business Overview
11.9.3 Perkin Elmer Next Generation Sequencing Sample Preparation Introduction
11.9.4 Perkin Elmer Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.9.5 Perkin Elmer Recent Development
11.10 PierianDx
11.10.1 PierianDx Company Detail
11.10.2 PierianDx Business Overview
11.10.3 PierianDx Next Generation Sequencing Sample Preparation Introduction
11.10.4 PierianDx Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.10.5 PierianDx Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Detail
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Next Generation Sequencing Sample Preparation Introduction
11.11.4 QIAGEN Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.11.5 QIAGEN Recent Development
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Detail
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated Next Generation Sequencing Sample Preparation Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.12.5 Quest Diagnostics Incorporated Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Next Generation Sequencing Sample Preparation Introduction
11.13.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Congenica
11.14.1 Congenica Company Detail
11.14.2 Congenica Business Overview
11.14.3 Congenica Next Generation Sequencing Sample Preparation Introduction
11.14.4 Congenica Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.14.5 Congenica Recent Development
11.15 DNASTAR
11.15.1 DNASTAR Company Detail
11.15.2 DNASTAR Business Overview
11.15.3 DNASTAR Next Generation Sequencing Sample Preparation Introduction
11.15.4 DNASTAR Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.15.5 DNASTAR Recent Development
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Detail
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific Next Generation Sequencing Sample Preparation Introduction
11.16.4 Eurofins Scientific Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.16.5 Eurofins Scientific Recent Development
11.17 Roche
11.17.1 Roche Company Detail
11.17.2 Roche Business Overview
11.17.3 Roche Next Generation Sequencing Sample Preparation Introduction
11.17.4 Roche Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.17.5 Roche Recent Development
11.18 BGI
11.18.1 BGI Company Detail
11.18.2 BGI Business Overview
11.18.3 BGI Next Generation Sequencing Sample Preparation Introduction
11.18.4 BGI Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.18.5 BGI Recent Development
11.19 Bio-Rad Laboratories
11.19.1 Bio-Rad Laboratories Company Detail
11.19.2 Bio-Rad Laboratories Business Overview
11.19.3 Bio-Rad Laboratories Next Generation Sequencing Sample Preparation Introduction
11.19.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.19.5 Bio-Rad Laboratories Recent Development
11.20 Macrogen
11.20.1 Macrogen Company Detail
11.20.2 Macrogen Business Overview
11.20.3 Macrogen Next Generation Sequencing Sample Preparation Introduction
11.20.4 Macrogen Revenue in Next Generation Sequencing Sample Preparation Business (2019-2024)
11.20.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Agilent Technologies
Myriad Genetics
Oxford Nanopore Technologies
Foundation Medicine
Genomatix GmbH
Illumina
Pacific Biosciences of California
Partek Incorporated
Perkin Elmer
PierianDx
QIAGEN
Quest Diagnostics Incorporated
Thermo Fisher Scientific
Congenica
DNASTAR
Eurofins Scientific
Roche
BGI
Bio-Rad Laboratories
Macrogen
听
听
*If Applicable.
